The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Metabolic and Molecular Bases of Inherited Disease
Scriver, R. C. (1995) · Medical Entomology and Zoology · Cited by 12,101
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor
Acton, S., Rigotti, A., Landschulz, K. T., Xu, S., Hobbs, H. H., & Krieger, M. (1996) · Science · doi:10.1126/science.271.5248.518 · Cited by 2,026
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Consensus development conference on antipsychotic drugs and obesity and diabetes
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, & North American Association for the Study of Obesity (2004) · Diabetes Care · doi:10.2337/diacare.27.2.596 · Cited by 1,554
Biochemistry of Lipids, Lipoproteins and Membranes
(2021) · Elsevier eBooks · doi:10.1016/c2020-0-00089-7 · Cited by 1,400
Ishibashi, S., Brown, M. S., Goldstein, J. L., Gerard, R. D., Hammer, R. E., & Herz, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116663 · Cited by 1,354
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
Boehm, G., Racoosin, J. A., Laughren, T. P., & Katz, R. (2004) · Diabetes Care · doi:10.2337/diacare.27.8.2088-a · Cited by 1,204
A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine
Powell, L. M., Wallis, S. C., Pease, R. J., Edwards, Y. H., Knott, T. J., & Scott, J. (1987) · Cell · doi:10.1016/0092-8674(87)90510-1 · Cited by 1,038
Effect of Torcetrapib on the Progression of Coronary Atherosclerosis
Nissen, S. E., Tardif, J.-C., Nicholls, S. J., Revkin, J. H., Shear, C. L., Duggan, W. T., Ruzyllo, W., Bachinsky, W. B., Lasala, G. P., & Tuzcu, E. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070635 · Cited by 966
Plasma cholesteryl ester transfer protein
Tall, A. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36957-1 · Cited by 953
Piedrahita, J. A., Zhang, S. H., Hagaman, J. R., Oliver, P. M., & Maeda, N. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4471 · Cited by 944
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13992 · Cited by 908
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
Eggimann, P., Garbino, J., & Pittet, D. (2003) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00801-6 · Cited by 900
Grunfeld, C. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.74.5.1045 · Cited by 848
Expression cloning of SR-BI, a CD36-related class B scavenger receptor.
Acton, S. L., Scherer, P. E., Lodish, H. F., & Krieger, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31921-x · Cited by 821
Molecular regulation of HDL metabolism and function: implications for novel therapies
Rader, D. J. (2006) · Journal of Clinical Investigation · doi:10.1172/jci30163 · Cited by 599
Saito, A., Pietromonaco, S., Loo, A. K., & Farquhar, M. G. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9725 · Cited by 563
Mouse Models for Atherosclerosis and Pharmaceutical Modifiers
Zadelaar, S., Kleemann, R., Verschuren, L., de Vries-Van der Weij, J., van der Hoorn, J., Princen, H. M., & Kooistra, T. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.142570 · Cited by 527
Novel antipsychotics: comparison of weight gain liabilities.
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · PubMed · Cited by 523
The Zucker-fatty rat: a review.
Bray, G. A. (1977) · PubMed · Cited by 517
Central Nervous System Toxicity after Liver Transplantation
de Groen, P. C., Aksamit, A. J., Rakela, J., Forbes, G. S., & Krom, R. A. F. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710013171404 · Cited by 498
HDL as a target in the treatment of atherosclerotic cardiovascular disease
Linsel-Nitschke, P., & Tall, A. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1658 · Cited by 486
Regulation of the activity of the low density lipoprotein receptor in human fibroblasts
Brown, M. S., & Goldstein, J. L. (1975) · Cell · doi:10.1016/0092-8674(75)90182-8 · Cited by 482
Ishibashi, S., Herz, J., Maeda, N., Goldstein, J. L., & Brown, M. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.10.4431 · Cited by 430
(2021) · Journal of Lipid Research · doi:10.1194/jlr · Cited by 427
St-Pierre, A. C., Cantin, B., Dagenais, G. R., Mauriège, P., Bernard, P.-M., Després, J.-P., & Lamarche, B. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000154144.73236.f4 · Cited by 422
"Compendium of pharmaceuticals and specialties".
Krogh, C. (1983) · PubMed · Cited by 411
Novel Antipsychotics: Comparison of Weight Gain Liabilities
Wirshing, D. A., Wirshing, W. C., Kysar, L., Berisford, M. A., Goldstein, D., Pashdag, J., Mintz, J., & Marder, S. R. (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0602 · Cited by 393
Evidence that epithelial glycoprotein 330/megalin mediates uptake of polybasic drugs.
Moestrup, S. K., Cui, S., Vorum, H., Bregengård, C., Bjørn, S. E., Norris, K., Gliemann, J., & Christensen, E. I. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118176 · Cited by 339
Brown, M. S., Faust, J. R., & Goldstein, J. L. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107989 · Cited by 321
Hepatic catabolism of rat and human lipoproteins in rats treated with 17 alpha-ethinyl estradiol.
Chao, Y. S., Windler, E. E., Chen, G. C., & Havel, R. J. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86494-3 · Cited by 317
STRUCTURE AND PHYSIOLOGIC FUNCTION OF THE LOW-DENSITY LIPOPROTEIN RECEPTOR
Jeon, H., & Blacklow, S. C. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.082803.133354 · Cited by 310
Cholesteryl ester exchange protein in human plasma isolation and characterization
Pattnaik, N. M., Montes, A., Hughes, L. B., & Zilversmit, D. B. (1978) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(78)90163-7 · Cited by 302
El‐Sadr, W., Mullin, C., Carr, A., Gibert, C., Rappoport, C., Visnegarwala, F., Grunfeld, C., & Raghavan, S. (2005) · HIV Medicine · doi:10.1111/j.1468-1293.2005.00273.x · Cited by 284
Qiu, X., Mistry, A., Ammirati, M. J., Chrunyk, B. A., Clark, R. W., Cong, Y., Culp, J. S., Danley, D. E., Freeman, T. B., Geoghegan, K. F., et al. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1197 · Cited by 277
May, P., Woldt, E., Matz, R. L., & Boucher, P. (2007) · Annals of Medicine · doi:10.1080/07853890701214881 · Cited by 267
Medical Risk in Patients With Bipolar Disorder and Schizophrenia
Newcomer, J. W. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.1106e16 · Cited by 264
Serum High-Density Lipoprotein Cholesterol, Metabolic Profile, and Breast Cancer Risk
Furberg, A.-S., Veierod, M. B., Wilsgaard, T., Bernstein, L., & Thune, I. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh216 · Cited by 264
The Zucker rat model of obesity, insulin resistance, hyperlipidemia, and renal injury.
Kasiske, B. L., O'Donnell, M. P., & Keane, W. F. (1992) · Hypertension · doi:10.1161/01.hyp.19.1_suppl.i110 · Cited by 263
Lipophilicity in PK design: methyl, ethyl, futile
van de Waterbeemd, H., Smith, D. A., & Jones, B. C. (2001) · Journal of Computer-Aided Molecular Design · doi:10.1023/a:1008192010023 · Cited by 244
Antifungal Agents Useful in Therapy of Systemic Fungal Infections
Medoff, G., Brajtburg, J., Kobayashi, G. S., & Bolard, J. (1983) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.23.040183.001511 · Cited by 236
The hyperlipidemic hamster as a model of experimental atherosclerosis
Nistor, A., Bulla, A., Filip, D. A., & Radu, A. (1987) · Atherosclerosis · doi:10.1016/0021-9150(87)90106-7 · Cited by 223
Isolation and characterization of a human serum cholesteryl ester transfer protein.
Chajek, T., & Fielding, C. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.7.3445 · Cited by 223
The low-density lipoprotein receptor gene family: a cellular Swiss army knife?
Nykjaer, A., & Willnow, T. E. (2002) · Trends in Cell Biology · doi:10.1016/s0962-8924(02)02282-1 · Cited by 221
Apolipoprotein E receptors: linking brain development and alzheimer's disease
Herz, J., & Beffert, U. (2000) · Nature Reviews Neuroscience · doi:10.1038/35036221 · Cited by 219
Megalin Deficiency Offers Protection from Renal Aminoglycoside Accumulation
Schmitz, C., Hilpert, J., Jacobsen, C., Boensch, C., Christensen, E. I., Luft, F. C., & Willnow, T. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109959200 · Cited by 215
MAHLEY, R. W., & WEISGRABER, K. H. (1974) · Circulation Research · doi:10.1161/01.res.35.5.713 · Cited by 201
Tall, A. R., Abreu, E., & Shuman, J. (1983) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)32904-1 · Cited by 193
Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA
Jiang, X. C., Moulin, P., Quinet, E., Goldberg, I. J., Yacoub, L. K., Agellon, L. B., Compton, D., Schnitzer-Polokoff, R., & Tall, A. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64369-1 · Cited by 187
Vitols, S., Björkholm, M., Gahrton, G., & Peterson, C. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92679-0 · Cited by 187
Feingold, K. R., Krauss, R. M., Pang, M., Doerrler, W., Jensen, P., & Grunfeld, C. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.6.8501146 · Cited by 183
Lipoprotein receptors: new roles for ancient proteins
Willnow, T. E., Nykjaer, A., & Herz, J. (1999) · Nature Cell Biology · doi:10.1038/14109 · Cited by 181
HEREDITARY OBESITY IN THE RAT ASSOCIATED WITH HYPERLIPEMIA*
Zucker, L. M. (1965) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1965.tb34810.x · Cited by 178
Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects
Fiorenza, A. M., Branchi, A., & Sommariva, D. (2000) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990070013 · Cited by 172
Primer: histopathology of calcineurin-inhibitor toxicity in renal allografts
Liptak, P., & Ivanyi, B. (2006) · Nature Clinical Practice Nephrology · doi:10.1038/ncpneph0225 · Cited by 165
Schizophrenia and obesity: impact of antipsychotic medications.
Wirshing, D. A. (2004) · PubMed · Cited by 162
Cyclosporine, Low-Density Lipoprotein, and Cholesterol
de GROEN, P. C. (1988) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)64916-7 · Cited by 159
Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake
Chung, N. S., & Wasan, K. M. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.12.003 · Cited by 158
Self-citationPharmacokinetics of halofantrine in man: effects of food and dose size.
Milton, K. A., Edwards, G., Ward, S. A., Orme, M., & Breckenridge, A. (1989) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1989.tb03507.x · Cited by 156
Pajukanta, P., Terwilliger, J. D., Perola, M., Hiekkalinna, T., Nuotio, I. O., Ellonen, P., Parkkonen, M., Hartiala, J., Ylitalo, K., Pihlajamäki, J., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302365 · Cited by 155
Pardridge, W. M. (1979) · Endocrinology · doi:10.1210/endo-105-3-605 · Cited by 153
Associations Between Bipolar Disorder and Metabolic Syndrome: A Review
Taylor, V., & MacQueen, G. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0704 · Cited by 152
Role of Plasma Lipoproteins in Modifying the Biological Activity of Hydrophobic Drugs
Wasan, K. M., & Cassidy, S. M. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js970407a · Cited by 146
Self-citationA 4-Fold Risk of Metabolic Syndrome in Patients With Schizophrenia
Saari, K. M., Lindeman, S. M., Viilo, K. M., Isohanni, M. K., Järvelin, M., Laurén, L., Savolainen, M. J., & Koponen, H. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0503 · Cited by 146
Vitols, S., Angelin, B., Ericsson, S., Gahrton, G., Juliusson, G., Masquelier, M., Paul, C., Peterson, C., Rudling, M. J., & Söderberg-Reid, K. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.7.2598 · Cited by 132
A physicochemical Basis for the Effect of Food on the Absolute Oral Bioavailability of Halofantrine
Humberstone, A., Porter, C. J. H., & Charman, W. N. (1996) · Journal of Pharmaceutical Sciences · doi:10.1021/js950472p · Cited by 132
Role of megalin in renal handling of aminoglycosides
Nagai, J., Tanaka, H., Nakanishi, N., Murakami, T., & Takano, M. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.2.f337 · Cited by 126
Gupta, S. K., Manfro, R. C., Tomlanovich, S. J., Gambertoglio, J. G., Garovoy, M. R., & Benet, L. Z. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb01868.x · Cited by 122
Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B
Oda, M. N., Hargreaves, P. L., Beckstead, J. A., Redmond, K. A., van Antwerpen, R., & Ryan, R. O. (2005) · Journal of Lipid Research · doi:10.1194/jlr.d500033-jlr200 · Cited by 113
Tsutsumi, K., Hagi, A., & Inoue, Y. (2001) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.24.579 · Cited by 101
Emerging Therapies Targeting High-Density Lipoprotein Metabolism and Reverse Cholesterol Transport
Duffy, D., & Rader, D. J. (2006) · Circulation · doi:10.1161/circulationaha.105.593855 · Cited by 101
High density lipoprotein complexes as delivery vehicles for anticancer drugs.
Lacko, A. G., Nair, M. P., Paranjape, S., Johnso, S., & McConathy, W. J. (2002) · PubMed · Cited by 100
Chueh, S., & Kahan, B. D. (2003) · Transplantation · doi:10.1097/01.tp.0000074310.40484.94 · Cited by 98
Current Role of Therapy with Amphotericin B
Meyer, R. D. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.supplement_1.s154 · Cited by 98
Drug-related dyslipidemia after renal transplantation
Mathis, A. S., Dave, N. J., Knipp, G. T., & Friedman, G. S. (2004) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/61.6.565 · Cited by 97
Wout, Z. G., Pec, E. A., Maggiore, J. A., et al. (1993) · PubMed · Cited by 96
Long-term problems related to immunosuppression
López, M. M., VALENZUELA, J. E., Álvarez, F. C., López-Álvarez, M. R., Salgado‐Cecilia, G., & Paricio, P. P. (2006) · Transplant Immunology · doi:10.1016/j.trim.2006.09.018 · Cited by 95
Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat‐meal rat models
Shayeganpour, A., Jun, A. S., & Brocks, D. R. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.457 · Cited by 91
Self-citationPussinen, P. J., Karten, B., Wintersperger, A., Reicher, H., McLean, M. P., Malle, E., & Sattler, W. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3490559 · Cited by 90
Wasan, K. M., Brazeau, G. A., Keyhani, A., Hayman, A. C., & Lopez‐Berestein, G. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.2.246 · Cited by 90
Self-citationGarg, A., & Simha, V. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0275 · Cited by 89
Interaction of cyclosporin A with human lipoproteins
Sgoutas, D. S., MacMahon, W., Love, A., et al. (1986) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1986.tb03085.x · Cited by 87
Hypertriglyceridemia as a possible risk factor for prostate cancer
Würmli, L., Joerger, M., Henz, S., Schmid, H., Riesen, W. F., Thomas, G., Krek, W., Cerny, T., & Gillessen, S. (2005) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500834 · Cited by 85
Influence of lipoproteins on renal cytotoxicity and antifungal activity of amphotericin B
Wasan, K. M., Rosenblum, M. G., Cheung, L. H., & Lopez‐Berestein, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.223 · Cited by 84
Self-citationTrichosanthin Interacts with and Enters Cells via LDL Receptor Family Members
Chan, W.-L., Shaw, P., Tam, S.-C., Jacobsen, C. B., Gliemann, J., & Nielsen, M. S. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2441 · Cited by 83
Wasan, K. M., Morton, R. E., Rosenblum, M. G., & Lopez‐Berestein, G. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830716 · Cited by 82
Self-citationNiemeier, A., Kassem, M. S., Toedter, K., Wendt, D., Ruether, W., Beisiegel†, U., & Heeren, J. (2005) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.041102 · Cited by 82
Poloxamer 407-mediated alterations in the activities of enzymes regulating lipid metabolism in rats.
Wasan, K. M., Subramanian, R., Kwong, M., Goldberg, I. J., Wright, T., & Johnston, T. P. (2003) · PubMed · Cited by 73
Self-citationRossignol, D. P., Wasan, K. M., Choo, E., Yau, E. H., Wong, N., Rose, J., Moran, J., & Lynn, M. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.9.3233-3240.2004 · Cited by 72
Self-citationChanges in plasma lipoproteins in acute malaria
Nilsson-Ehle, I., & Nilsson‐Ehle, P. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00136.x · Cited by 69
Altered plasma lipid pattern in falciparum malaria
Mohanty, S., Mishra, S. K., Das, B. S., Satpathy, S. K., Mohanty, D., Patnaik, J. K., & Bose, T. (1992) · Annals of Tropical Medicine and Parasitology · doi:10.1080/00034983.1992.11812715 · Cited by 68
High-Fat Meals Increase the Clearance of Cyclosporine
Gupta, S. K., & Benet, L. Z. (1990) · Pharmaceutical Research · doi:10.1023/a:1015831408425 · Cited by 67
Rodrigues, D. G., Covolan, C. C., Coradi, S. T., et al. (2002) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357021779104 · Cited by 67
HIGH CYCLOSPORIN LEVELS AFTER BONE MARROW TRANSPLANTATION ASSOCIATED WITH HYPERTRIGLYCERIDAEMIA
Nemunaitis, J. J. (1986) · The Lancet · doi:10.1016/s0140-6736(86)90254-0 · Cited by 67
α2‐Macroglobulin Receptor Mediates Binding and Cytotoxicity of Plant Ribosome‐Inactivating Proteins
Cavallaro, U., Nykjær, A., Nielsen, M. S., & Soria, M. R. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20795.x · Cited by 65
Humberstone, A., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js9704846 · Cited by 60
Influence of blood components on the tissue uptake indices of cyclosporin in rats.
Lemaire, M., Pardridge, W. M., & Chaudhuri, G. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24506-2 · Cited by 60
SPYDEVOLD, S. O., Greenbaum, A. L., Baquer, N. Z., & McLean, P. (1978) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1978.tb12534.x · Cited by 59
The metabolic basis of atherogenic dyslipidemia
Vinik, A. I. (2005) · Clinical cornerstone · doi:10.1016/s1098-3597(05)80065-1 · Cited by 58
Dumont, L., Gautier, T., de Barros, J.-P. P., Laplanche, H., Blache, D., Ducoroy, P., Fruchart, J., Fruchart, J., Gambert, P., Masson, D., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504678200 · Cited by 57
Pathogenesis of lipodystrophy and lipid abnormalities in patients taking antiretroviral therapy.
Mallon, P. W. G. (2007) · PubMed · Cited by 55
Dynamics of lipoprotein transport in the human circulatory system
Fielding, P. E., & Fielding, C. J. (2002) · New comprehensive biochemistry · doi:10.1016/s0167-7306(02)36022-8 · Cited by 51
Potential application of plant lipid transfer proteins for drug delivery
Pato, C., Borgne, M. L., Baut, G. L., Pape, P. L., Marion, D., & Douliez, J. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00708-0 · Cited by 51
Rensen, P. C. N., Schiffelers, R. M., Versluis, A. J., Bijsterbosch, M. K., Kuijk-Meuwissen, M. E. M. J. V., & van Berkel, T. J. C. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.445 · Cited by 49
Mechanism of Prebeta-HDL Formation and Activation
Chau, P., Nakamura, Y. K., Fielding, C. J., & Fielding, P. E. (2006) · Biochemistry · doi:10.1021/bi052535g · Cited by 48
Jonas, A. (2002) · New comprehensive biochemistry · doi:10.1016/s0167-7306(02)36020-4 · Cited by 43
Wasan, K. M., Grossie, V. B., & Lopez‐Berestein, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2224 · Cited by 41
Self-citationKim, M.-S., Wang, S., Shen, Z., Kochansky, C. J., Strauss, J. R., Franklin, R. B., & Vincent, S. H. (2004) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)02972-6 · Cited by 40
Lakkaraju, A., Rahman, Y. E., & Dubinsky, J. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111764200 · Cited by 40
Versluis, A., Rensen, P. C. N., Rump, E. T., van Berkel, T. J. C., & Bijsterbosch, M. K. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.730 · Cited by 39
León, C., Wasan, K. M., Sachs‐Barrable, K., & Johnston, T. P. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0276-8 · Cited by 39
Self-citationScherphof, G. L., Leeuwen, B. V., Wilschut, J., & Damen, J. (1983) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(83)90236-5 · Cited by 39
Effects of Hyperlipidemia on the Pharmacokinetics of Nifedipine in the Rat
Eliot, L., Foster, R. T., & Jamali, F. (1999) · Pharmaceutical Research · doi:10.1023/a:1018896912889 · Cited by 38
Ramaswamy, M., Peteherych, K. D., Kennedy, A. L., & Wasan, K. M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1184-1191.2001 · Cited by 37
Self-citationHughes, T. A., Gaber, A. O., & Montgomery, C. E. (1991) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199107000-00002 · Cited by 36
Johnston, T. P., Baker, J. C., Jamal, A. S., Hall, D., Emeson, E. E., & Palmer, W. K. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199912000-00010 · Cited by 35
Wojcicki, J., Jaroszynska, M., Droździk, M., et al. (2003) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.357 · Cited by 34
Cassidy, S. M., Strobel, F. W., & Wasan, K. M. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1878 · Cited by 33
Self-citationThe unfolding story of megalin (gp330): now recognized as a drug receptor.
Farquhar, M. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118149 · Cited by 32
Versluis, A. J., Rump, E. T., Rensen, P. C. N., van Berkel, T. J. C., & Bijsterbosch, M. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38099-1 · Cited by 31
Amin, K., Wasan, K. M., Albrecht, R. M., & Heath, T. D. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10075 · Cited by 29
Self-citationKoller-Lucae, S. K. M., Schott, H. N., & Schwendener, R. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690558 · Cited by 29
Assembly and secretion of lipoproteins
Vance, J. E. (2002) · New comprehensive biochemistry · doi:10.1016/s0167-7306(02)36021-6 · Cited by 28
Emerging Indications for the Use of Cyclosporin in Organ Transplantation and Autoimmunity
Keown, P. A. (1990) · Drugs · doi:10.2165/00003495-199040030-00001 · Cited by 28
McIntosh, M. P., Porter, C. J. H., Wasan, K. M., Ramaswamy, M., & Wasan, K. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980152g · Cited by 27
Self-citationA kinetic study of the oxidation effects of amphotericin B on human low‐density lipoproteins
Barwicz, J., Gruda, I., & Tancrède, P. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01731-7 · Cited by 27
Rapid cycling bipolar disorder: historical overview and focus on emerging treatments
Mackin, P., & Young, A. H. (2004) · Bipolar Disorders · doi:10.1111/j.1399-5618.2004.00156.x · Cited by 26
Wasan, K. M., Ramaswamy, M., McIntosh, M. P., et al. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js980353k · Cited by 23
Self-citationTungsiripat, M., & Aberg, J. A. (2005) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.72.12.1113 · Cited by 22
Kennedy, A. L., & Wasan, K. M. (1999) · Journal of Pharmaceutical Sciences · doi:10.1021/js990101z · Cited by 21
Self-citationLipoprotein receptors and the genetic control of cholesterol metabolism in cultured human cells
Brown, M. S., & Goldstein, J. L. (1975) · Die Naturwissenschaften · doi:10.1007/bf00625346 · Cited by 20
Effects of Pravastatin on Plasma Lipid Concentrations in Poloxamer 407‐Induced Hyperlipidemic Rats
Porter, J. A., Carter, B. L., Johnston, T. P., & Palmer, W. K. (1995) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1995.tb04336.x · Cited by 16
Partial suppression of CETP activity beneficially modifies the lipid transfer profile of plasma
Morton, R. E., & Greene, D. J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.06.030 · Cited by 15
Wasan, K. M., Donnachie, E., Seccombe, D. W., & Pritchard, P. H. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10249 · Cited by 7
Self-citation
Cited by
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
The journey of a drug-carrier in the body: An anatomo-physiological perspective
Bertrand, N., & Leroux, J.-C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.098 · Cited by 707
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.04.003 · Cited by 385
Amphiphile nanoarchitectonics: from basic physical chemistry to advanced applications
Ramanathan, M., Shrestha, L. K., Mori, T., Ji, Q., Hill, J. P., & Ariga, K. (2013) · Physical Chemistry Chemical Physics · doi:10.1039/c3cp50620g · Cited by 353
Kidambi, S., Yarmush, R. S., Novik, E., Chao, P., Yarmush, M. L., & Nahmias, Y. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906820106 · Cited by 213
Metadata
- Authors
- Wasan, K. M., Brocks, D. R., Lee, S. D., Sachs-Barrable, K., & Thornton, S. J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-01
- Volume
- 7
- Issue
- 1
- Pages
- 84-99
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2020459876
- Cited by
- 269
- References
- 137
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.